GENTAMICIN SULFATE

GENTAMICIN SULFATE was reported 15943 times

GENTAMICIN SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NORMAL LABOUR 122 0.8714
1 BARTTER'S SYNDROME 14 0.3684
2 NEONATAL CANDIDA INFECTION 13 0.3023
3 UMBILICAL ERYTHEMA 15 0.2459
4 HAEMATOPOIETIC STEM CELL MOBILISATION 15 0.2344
5 DELIVERY 126 0.1912
6 ENDOCARDITIS CANDIDA 13 0.1711
7 DELUSION OF GRANDEUR 61 0.1359
8 AMINOACIDURIA 16 0.1006
9 PERSISTENT GENITAL AROUSAL DISORDER 22 0.0948
10 SPINAL MUSCULAR ATROPHY 24 0.0889
11 CONGENITAL MULTIPLEX ARTHROGRYPOSIS 18 0.0882
12 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 35 0.0862
13 OROPHARYNGEAL OEDEMA 12 0.0828
14 OSCILLOPSIA 21 0.0811
15 VESTIBULAR DISORDER 95 0.0776
16 OTOTOXICITY 139 0.0751
17 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 21 0.0680
18 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 32 0.0658
19 CARDIAC VALVE VEGETATION 29 0.0597
20 CONDUCTIVE DEAFNESS 19 0.0592
21 ANAEMIA FOLATE DEFICIENCY 11 0.0570
22 GEOTRICHUM INFECTION 12 0.0569
23 SPLENIC ABSCESS 20 0.0491
24 STOMA CLOSURE 15 0.0482
25 RESPIRATORY TRACT INFECTION BACTERIAL 23 0.0462
26 POSITIVE AIRWAY PRESSURE THERAPY 13 0.0445
27 NECROTISING ENTEROCOLITIS NEONATAL 18 0.0443
28 LYMPHOCYTE COUNT ABNORMAL 49 0.0435
29 FUNGAL ENDOCARDITIS 13 0.0432
30 ABDOMINAL COMPARTMENT SYNDROME 27 0.0424
31 PNEUMOCOCCAL SEPSIS 27 0.0411
32 CNS VENTRICULITIS 13 0.0399
33 BACILLUS INFECTION 25 0.0396
34 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 41 0.0386
35 MOTOR NEURONE DISEASE 18 0.0370
36 ENDOCARDITIS BACTERIAL 28 0.0356
37 SEPSIS SYNDROME 17 0.0339
38 HYPERPARATHYROIDISM SECONDARY 78 0.0311
39 SEPSIS NEONATAL 25 0.0308
40 ANISOCYTOSIS 20 0.0304
41 PYROGLUTAMIC ACIDOSIS 12 0.0302
42 NECROTISING COLITIS 38 0.0300
43 CRYSTALLURIA 16 0.0294
44 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 15 0.0294
45 LISTERIOSIS 32 0.0289
46 EPIDERMOLYSIS 13 0.0283
47 LINEAR IGA DISEASE 47 0.0282
48 DISSEMINATED MUCORMYCOSIS 11 0.0279
49 SCROTAL PAIN 14 0.0259
50 MYOPERICARDITIS 20 0.0256
51 SERRATIA INFECTION 19 0.0255
52 SEPTIC EMBOLUS 21 0.0252
53 RENAL TUBULAR NECROSIS 247 0.0252
54 INFECTIVE ANEURYSM 12 0.0242
55 NEPHROGENIC ANAEMIA 112 0.0242
56 ACINETOBACTER INFECTION 26 0.0237
57 NEPHRITIS INTERSTITIAL 30 0.0237
58 DEAFNESS NEUROSENSORY 78 0.0237
59 ENDOCARDITIS 119 0.0232
60 LIVER ABSCESS 75 0.0231
61 ASPERGILLOSIS 30 0.0230
62 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 73 0.0225
63 MYCOBACTERIUM ABSCESSUS INFECTION 16 0.0224
64 NEONATAL DISORDER 35 0.0221
65 CEREBRAL PALSY 21 0.0221
66 PATHOGEN RESISTANCE 195 0.0214
67 METABOLIC ALKALOSIS 34 0.0212
68 ABSCESS NECK 14 0.0207
69 NUTRITIONAL CONDITION ABNORMAL 14 0.0201
70 GRUNTING 12 0.0200
71 ENTEROCOCCAL SEPSIS 16 0.0198
72 EXCESSIVE EYE BLINKING 29 0.0196
73 RHINALGIA 53 0.0193
74 ISCHAEMIC CEREBRAL INFARCTION 22 0.0189
75 DEATH NEONATAL 26 0.0187
76 JOINT CONTRACTURE 20 0.0186
77 KLEBSIELLA TEST POSITIVE 12 0.0184
78 FUNGAEMIA 29 0.0184
79 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 15 0.0182
80 PREMATURE DELIVERY 290 0.0182
81 AMNIOTIC CAVITY INFECTION 13 0.0180
82 BACTERIAL DISEASE CARRIER 13 0.0178
83 SYSTEMIC CANDIDA 44 0.0175
84 BRADYCARDIA NEONATAL 22 0.0175
85 ENTEROCOCCAL BACTERAEMIA 18 0.0170
86 STENOTROPHOMONAS INFECTION 23 0.0169
87 NEPHROPATHY TOXIC 190 0.0169
88 FOLATE DEFICIENCY 19 0.0164
89 SKIN TEST POSITIVE 15 0.0161
90 HYPOPARATHYROIDISM 12 0.0156
91 CHRONIC HEPATITIS 12 0.0148
92 MACROCYTOSIS 17 0.0147
93 LYMPHADENECTOMY 14 0.0143
94 TOXIC EPIDERMAL NECROLYSIS 216 0.0142
95 URINARY TRACT INFECTION ENTEROCOCCAL 13 0.0139
96 RESUSCITATION 23 0.0139
97 NEONATAL RESPIRATORY DISTRESS SYNDROME 49 0.0138
98 FUNGAL PERITONITIS 21 0.0138
99 NEONATAL RESPIRATORY DISTRESS 13 0.0138
100 ENTEROBACTER INFECTION 23 0.0137
101 LUNG CONSOLIDATION 38 0.0136
102 PARAPARESIS 24 0.0135
103 STAPHYLOCOCCAL SEPSIS 66 0.0134
104 HYPOPERFUSION 14 0.0133
105 ENTEROCOCCAL INFECTION 64 0.0132
106 CLOSTRIDIUM COLITIS 16 0.0132
107 METHAEMOGLOBINAEMIA 30 0.0129
108 SPUTUM INCREASED 28 0.0129
109 OLIGURIA 80 0.0129
110 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 100 0.0129
111 SYSTEMIC MYCOSIS 15 0.0128
112 PREMATURE BABY 382 0.0127
113 SYSTEMIC INFECTION 21 0.0127
114 END STAGE RENAL DISEASE 224 0.0123
115 BRONCHIAL DISORDER 19 0.0122
116 PYURIA 12 0.0121
117 LYMPHOCYTIC INFILTRATION 12 0.0119
118 RASH MORBILLIFORM 33 0.0119
119 KLEBSIELLA INFECTION 60 0.0119
120 NEUTROPENIC SEPSIS 84 0.0117
121 BLOOD CULTURE POSITIVE 35 0.0117
122 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 300 0.0116
123 PSEUDOMEMBRANOUS COLITIS 25 0.0112
124 EOSINOPHILIA 192 0.0109
125 RENAL FAILURE ACUTE 463 0.0109
126 INCREASED BRONCHIAL SECRETION 27 0.0105
127 CHEST X-RAY ABNORMAL 32 0.0104
128 MUCORMYCOSIS 27 0.0104
129 MULTI-ORGAN FAILURE 179 0.0103
130 COAGULATION TIME PROLONGED 16 0.0103
131 RENAL TUBULAR DISORDER 29 0.0103
132 AORTIC VALVE INCOMPETENCE 43 0.0101
133 INTRAVENTRICULAR HAEMORRHAGE 25 0.0100
134 DEAFNESS BILATERAL 17 0.0100
135 RESPIRATORY ALKALOSIS 16 0.0098
136 LOW BIRTH WEIGHT BABY 77 0.0097
137 STAPHYLOCOCCAL BACTERAEMIA 42 0.0097
138 CYTOLYTIC HEPATITIS 32 0.0096
139 OTITIS MEDIA 31 0.0094
140 ENDOCRINE DISORDER 12 0.0094
141 REBOUND ACID HYPERSECRETION 28 0.0092
142 PERITONITIS BACTERIAL 93 0.0092
143 MULTIPLE ORGAN DYSFUNCTION SYNDROME 260 0.0092
144 HAEMODYNAMIC INSTABILITY 68 0.0089
145 SEPTIC SHOCK 386 0.0089
146 CLOSTRIDIAL INFECTION 30 0.0089
147 CANDIDA INFECTION 149 0.0088
148 TUBULOINTERSTITIAL NEPHRITIS 163 0.0087
149 AORTIC VALVE DISEASE 14 0.0087
150 AFFECTIVE DISORDER 68 0.0086
151 VASCULAR DEVICE INFECTION 39 0.0086
152 DIPLEGIA 17 0.0086
153 CARDIAC VENTRICULAR THROMBOSIS 11 0.0085
154 ARTHRITIS BACTERIAL 35 0.0085
155 INTERVERTEBRAL DISCITIS 16 0.0085
156 BRAIN ABSCESS 21 0.0083
157 FOOT AMPUTATION 12 0.0082
158 INHIBITORY DRUG INTERACTION 13 0.0082
159 PNEUMONIA KLEBSIELLA 15 0.0082
160 MULTIPLE-DRUG RESISTANCE 25 0.0081
161 POTENTIATING DRUG INTERACTION 27 0.0080
162 TOXIC SKIN ERUPTION 81 0.0080
163 CORNEAL OEDEMA 18 0.0080
164 RESPIRATORY DISORDER NEONATAL 13 0.0080
165 DRUG RESISTANCE 206 0.0080
166 BACTERIAL SEPSIS 26 0.0080
167 HAEMODIALYSIS 67 0.0080
168 ACUTE KIDNEY INJURY 1218 0.0080
169 PSEUDOMONAS INFECTION 68 0.0079
170 PULMONARY HAEMORRHAGE 62 0.0079
171 ESCHERICHIA INFECTION 64 0.0078
172 CLOSTRIDIUM TEST POSITIVE 17 0.0077
173 HYPOTONIA NEONATAL 12 0.0077
174 HYPERSENSITIVITY VASCULITIS 20 0.0076
175 NEUTROPHIL COUNT INCREASED 78 0.0076
176 ANURIA 65 0.0075
177 ENDOTRACHEAL INTUBATION 21 0.0075
178 LYMPHOCYTOSIS 16 0.0074
179 PSEUDOMONAL SEPSIS 13 0.0074
180 MECHANICAL VENTILATION 14 0.0074
181 JAUNDICE CHOLESTATIC 26 0.0074
182 POLYCYTHAEMIA 15 0.0073
183 INTESTINAL ISCHAEMIA 40 0.0073
184 RASH MACULO-PAPULAR 160 0.0072
185 CEREBRAL ISCHAEMIA 37 0.0072
186 STAPHYLOCOCCUS TEST POSITIVE 15 0.0071
187 NECROTISING FASCIITIS 25 0.0071
188 HISTIOCYTOSIS HAEMATOPHAGIC 21 0.0071
189 ENDOPHTHALMITIS 42 0.0070
190 TYPE IV HYPERSENSITIVITY REACTION 19 0.0069
191 RETROPERITONEAL HAEMORRHAGE 17 0.0069
192 NEPHRITIS 23 0.0069
193 MUCOSAL INFLAMMATION 179 0.0068
194 NOSOCOMIAL INFECTION 15 0.0068
195 DIVERTICULAR PERFORATION 14 0.0068
196 PERITONITIS 137 0.0066
197 PATENT DUCTUS ARTERIOSUS 26 0.0065
198 GLOMERULONEPHRITIS 16 0.0065
199 STRIDOR 19 0.0065
200 INFLAMMATORY MARKER INCREASED 32 0.0064
201 PURPURA 57 0.0064
202 APNOEA 50 0.0064
203 FIXED ERUPTION 11 0.0064
204 HUMAN HERPESVIRUS 6 INFECTION 12 0.0063
205 ELECTROCARDIOGRAM T WAVE INVERSION 14 0.0063
206 DISEASE COMPLICATION 29 0.0063
207 AKINESIA 13 0.0063
208 ASPERGILLUS INFECTION 41 0.0062
209 WOUND DEHISCENCE 21 0.0062
210 TALIPES 19 0.0061
211 HAEMOLYTIC URAEMIC SYNDROME 14 0.0060
212 EMPYEMA 12 0.0060
213 CLOSTRIDIUM DIFFICILE COLITIS 63 0.0059
214 NECROSIS 33 0.0059
215 HYPERNATRAEMIA 29 0.0058
216 METABOLIC ACIDOSIS 186 0.0058
217 HYPOTONIA 58 0.0058
218 DERMATITIS EXFOLIATIVE 29 0.0058
219 CLOSTRIDIUM DIFFICILE INFECTION 124 0.0057
220 THYROIDITIS 17 0.0057
221 DEMYELINATION 23 0.0056
222 CHRONIC KIDNEY DISEASE 425 0.0056
223 ATELECTASIS 54 0.0056
224 APPLICATION SITE SCAB 12 0.0056
225 DISSEMINATED INTRAVASCULAR COAGULATION 78 0.0055
226 CHOLESTASIS 106 0.0055
227 CANDIDIASIS 22 0.0055
228 VENOOCCLUSIVE LIVER DISEASE 27 0.0055
229 RENAL FAILURE 722 0.0054
230 PREMATURE RUPTURE OF MEMBRANES 13 0.0054
231 LYMPHOCYTE COUNT DECREASED 95 0.0054
232 BRAIN HERNIATION 16 0.0054
233 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 27 0.0053
234 CAPILLARY LEAK SYNDROME 11 0.0053
235 ATRIOVENTRICULAR BLOCK SECOND DEGREE 16 0.0053
236 SCHIZOPHRENIA 64 0.0053
237 KERATITIS 16 0.0053
238 ACUTE RESPIRATORY DISTRESS SYNDROME 93 0.0053
239 DRUG LEVEL INCREASED 87 0.0053
240 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 20 0.0052
241 DILATATION VENTRICULAR 11 0.0052
242 RENAL INJURY 155 0.0052
243 LUNG INFILTRATION 46 0.0052
244 PETECHIAE 54 0.0052
245 LEUKOCYTOSIS 93 0.0051
246 BILIRUBIN CONJUGATED INCREASED 12 0.0051
247 DERMATITIS BULLOUS 37 0.0051
248 HEPATOSPLENOMEGALY 13 0.0051
249 CEREBELLAR SYNDROME 11 0.0050
250 STEVENS-JOHNSON SYNDROME 111 0.0050
251 BACTERAEMIA 59 0.0050
252 FOETAL EXPOSURE DURING PREGNANCY 402 0.0049
253 CUTANEOUS VASCULITIS 18 0.0049
254 DERMATITIS EXFOLIATIVE GENERALISED 17 0.0049
255 COMA SCALE ABNORMAL 14 0.0048
256 METABOLIC DISORDER 28 0.0048
257 CATHETER SITE INFECTION 18 0.0048
258 CIRCULATORY COLLAPSE 81 0.0048
259 ULCERATIVE KERATITIS 13 0.0047
260 ARTHRITIS INFECTIVE 22 0.0047
261 HYPERBILIRUBINAEMIA 49 0.0047
262 HALLUCINATION, AUDITORY 75 0.0047
263 FEBRILE BONE MARROW APLASIA 20 0.0047
264 ESCHERICHIA URINARY TRACT INFECTION 20 0.0047
265 SHOCK HAEMORRHAGIC 38 0.0047
266 BONE MARROW DISORDER 14 0.0046
267 MITRAL VALVE INCOMPETENCE 52 0.0046
268 HYDROCEPHALUS 25 0.0046
269 HAEMOLYTIC ANAEMIA 41 0.0046
270 SEPSIS 509 0.0046
271 ANAPHYLACTIC REACTION 252 0.0046
272 THERAPEUTIC AGENT TOXICITY 15 0.0045
273 RESPIRATORY DISTRESS 124 0.0045
274 DRUG ERUPTION 79 0.0045
275 HYPERTHERMIA 34 0.0044
276 ACUTE PSYCHOSIS 11 0.0044
277 MATERNAL EXPOSURE DURING PREGNANCY 396 0.0044
278 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 22 0.0044
279 DRUG LEVEL ABOVE THERAPEUTIC 20 0.0044
280 DEVICE RELATED INFECTION 67 0.0043
281 STATUS EPILEPTICUS 49 0.0043
282 BRONCHOPULMONARY ASPERGILLOSIS 33 0.0043
283 PROTEIN TOTAL DECREASED 16 0.0042
284 DYSAESTHESIA 13 0.0042
285 RENAL IMPAIRMENT 354 0.0042
286 CONJUNCTIVAL HYPERAEMIA 15 0.0042
287 ODYNOPHAGIA 25 0.0042
288 PROTHROMBIN TIME PROLONGED 25 0.0042
289 EXFOLIATIVE RASH 11 0.0042
290 RENAL FAILURE CHRONIC 32 0.0042
291 HEPATOCELLULAR INJURY 59 0.0042
292 BLOOD ALBUMIN DECREASED 33 0.0042
293 ENCEPHALOPATHY 102 0.0041
294 ADENOVIRUS INFECTION 12 0.0041
295 GUILLAIN-BARRE SYNDROME 20 0.0041
296 ANGIONEUROTIC OEDEMA 11 0.0041
297 BLOOD UREA INCREASED 69 0.0041
298 TACHYPNOEA 56 0.0041
299 URINE OUTPUT DECREASED 36 0.0041
300 SARS-COV-2 TEST POSITIVE 54 0.0041
301 RESPIRATORY ACIDOSIS 16 0.0041
302 STAPHYLOCOCCAL INFECTION 133 0.0040
303 HYPERPYREXIA 17 0.0040
304 HEPATITIS ACUTE 26 0.0040
305 HEPATITIS CHOLESTATIC 24 0.0040
306 AGRANULOCYTOSIS 74 0.0040
307 PURULENT DISCHARGE 17 0.0040
308 NEPHROGENIC SYSTEMIC FIBROSIS 12 0.0040
309 TOXIC ENCEPHALOPATHY 20 0.0039
310 HYPOALBUMINAEMIA 30 0.0039
311 GINGIVAL SWELLING 17 0.0038
312 PERITONEAL DIALYSIS COMPLICATION 28 0.0038
313 COAGULOPATHY 64 0.0038
314 MOTOR DYSFUNCTION 39 0.0038
315 SHOCK 88 0.0038
316 EOSINOPHILIC PNEUMONIA 12 0.0038
317 BRONCHOPNEUMONIA 13 0.0038
318 STREPTOCOCCAL INFECTION 21 0.0038
319 CEREBRAL ATROPHY 15 0.0038
320 HYPOVOLAEMIA 22 0.0038
321 BLOOD CREATININE ABNORMAL 13 0.0038
322 AZOTAEMIA 15 0.0038
323 CREATININE RENAL CLEARANCE DECREASED 15 0.0037
324 HYDRONEPHROSIS 28 0.0037
325 BLOOD CREATININE INCREASED 244 0.0037
326 STUPOR 12 0.0037
327 STILLBIRTH 18 0.0037
328 SCOLIOSIS 23 0.0037
329 COLITIS ISCHAEMIC 25 0.0037
330 BLOOD ALKALINE PHOSPHATASE INCREASED 92 0.0037
331 ISCHAEMIA 17 0.0037
332 NEUTROPHILIA 21 0.0037
333 VASCULITIS 43 0.0037
334 BRAIN INJURY 37 0.0037
335 HYPERKALAEMIA 129 0.0037
336 DIALYSIS 52 0.0037
337 SKIN NECROSIS 19 0.0037
338 C-REACTIVE PROTEIN INCREASED 132 0.0036
339 ABDOMINAL TENDERNESS 18 0.0036
340 DRUG TOXICITY 49 0.0036
341 PULSELESS ELECTRICAL ACTIVITY 15 0.0036
342 DUODENITIS 11 0.0036
343 SKIN LESION 97 0.0035
344 ACIDOSIS 27 0.0035
345 MYOCLONUS 42 0.0035
346 DIFFICULTY IN WALKING 12 0.0035
347 GRAFT VERSUS HOST DISEASE 25 0.0035
348 GENERALISED OEDEMA 43 0.0035
349 FOETAL DEATH 18 0.0035
350 MENINGITIS 23 0.0034
351 FACE OEDEMA 58 0.0034
352 PERIPHERAL ISCHAEMIA 14 0.0034
353 ABDOMINAL ABSCESS 15 0.0034
354 BLOOD CREATINE INCREASED 15 0.0034
355 SKIN INFECTION 38 0.0034
356 INTESTINAL PERFORATION 38 0.0034
357 HAEMOLYSIS 26 0.0034
358 ILEUS PARALYTIC 15 0.0034
359 UROSEPSIS 31 0.0034
360 CHOLECYSTITIS ACUTE 19 0.0033
361 PYELONEPHRITIS 29 0.0033
362 PANCYTOPENIA 187 0.0033
363 EJECTION FRACTION DECREASED 52 0.0033
364 CELLULITIS 168 0.0033
365 HYPOCALCAEMIA 63 0.0033
366 EXTRAPYRAMIDAL DISORDER 82 0.0033
367 PNEUMONIA FUNGAL 13 0.0033
368 LEUKOPENIA 164 0.0033
369 THROMBOCYTOSIS 12 0.0033
370 HYPOXIA 115 0.0033
371 HEPARIN-INDUCED THROMBOCYTOPENIA 16 0.0032
372 WOUND HAEMORRHAGE 12 0.0032
373 THROMBOCYTOPENIA 362 0.0032
374 ATRIOVENTRICULAR BLOCK FIRST DEGREE 14 0.0032
375 HYPERCHLORHYDRIA 19 0.0032
376 HYPOKALAEMIA 149 0.0032
377 CHOLANGITIS 20 0.0032
378 FUNGAL SKIN INFECTION 13 0.0032
379 ERYTHEMA MULTIFORME 30 0.0032
380 BACTERIAL INFECTION 60 0.0032
381 ACUTE PULMONARY OEDEMA 18 0.0032
382 EXTRAVASATION 13 0.0032
383 NEUROTOXICITY 55 0.0031
384 MATERNAL DRUGS AFFECTING FOETUS 24 0.0031
385 MALNUTRITION 35 0.0031
386 HEPATITIS 80 0.0031
387 MYOSITIS 28 0.0031
388 C-REACTIVE PROTEIN ABNORMAL 20 0.0031
389 CAESAREAN SECTION 36 0.0031
390 CYTOMEGALOVIRUS INFECTION 51 0.0031
391 INTRACRANIAL PRESSURE INCREASED 17 0.0030
392 PNEUMONIA BACTERIAL 28 0.0030
393 ANHEDONIA 80 0.0030
394 BODY TEMPERATURE INCREASED 62 0.0030
395 TRICUSPID VALVE INCOMPETENCE 24 0.0030
396 PSYCHOTIC DISORDER 89 0.0030
397 SINUS BRADYCARDIA 29 0.0030
398 EOSINOPHIL COUNT INCREASED 25 0.0030
399 GANGRENE 18 0.0030
400 HYPOPHOSPHATAEMIA 22 0.0030
401 FEBRILE NEUTROPENIA 197 0.0030
402 FOLLICULITIS 31 0.0030
403 PETIT MAL EPILEPSY 15 0.0029
404 WOUND INFECTION 32 0.0029
405 DEAFNESS UNILATERAL 16 0.0029
406 NEPHROPATHY 27 0.0029
407 LARGE INTESTINE PERFORATION 20 0.0029
408 GASTROENTERITIS 42 0.0029
409 ATRIAL SEPTAL DEFECT 24 0.0029
410 ACUTE RESPIRATORY FAILURE 54 0.0028
411 COMPRESSION FRACTURE 15 0.0028
412 CARDIAC VALVE DISEASE 16 0.0028
413 ENTEROCOLITIS 16 0.0028
414 BRAIN OEDEMA 35 0.0028
415 FLUID OVERLOAD 40 0.0027
416 LYMPHOEDEMA 19 0.0027
417 RASH ERYTHEMATOUS 131 0.0027
418 PULMONARY HYPERTENSION 57 0.0027
419 PARONYCHIA 12 0.0027
420 RESPIRATORY FAILURE 199 0.0027
421 LIVER FUNCTION TEST ABNORMAL 79 0.0027
422 HAEMATURIA 93 0.0027
423 DEAFNESS 71 0.0027
424 FEAR 73 0.0027
425 CONJUNCTIVITIS 50 0.0027
426 DRUG INTERACTION 426 0.0027
427 ANAPHYLACTIC SHOCK 69 0.0027
428 PULMONARY ALVEOLAR HAEMORRHAGE 15 0.0027
429 BLOOD BILIRUBIN INCREASED 72 0.0027
430 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 20 0.0027
431 EMBOLISM 22 0.0026
432 JOINT DISLOCATION 28 0.0026
433 NYSTAGMUS 14 0.0026
434 GASTROINTESTINAL SOUNDS ABNORMAL 13 0.0026
435 IMMUNE THROMBOCYTOPENIA 12 0.0026
436 PYREXIA 902 0.0026
437 ENCEPHALITIS 18 0.0026
438 PNEUMONIA ASPIRATION 65 0.0026
439 PNEUMOTHORAX 41 0.0026
440 ASCITES 76 0.0026
441 ELECTROLYTE IMBALANCE 30 0.0026
442 CARDIOGENIC SHOCK 37 0.0026
443 NEUTROPENIA 349 0.0026
444 LIVER INJURY 63 0.0026
445 PATHOLOGICAL FRACTURE 13 0.0026
446 DYSLIPIDAEMIA 13 0.0026
447 POST PROCEDURAL COMPLICATION 49 0.0025
448 FUNGAL INFECTION 85 0.0025
449 RHABDOMYOLYSIS 106 0.0025
450 DRUG LEVEL BELOW THERAPEUTIC 14 0.0025
451 MUSCLE INJURY 21 0.0025
452 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 15 0.0025
453 BRONCHOSPASM 36 0.0025
454 HEPATIC FAILURE 76 0.0025
455 TRANSAMINASES INCREASED 56 0.0025
456 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 18 0.0025
457 TACHYCARDIA 222 0.0025
458 HYPOTENSION 498 0.0025
459 PREMATURE LABOUR 14 0.0025
460 GAMMA-GLUTAMYLTRANSFERASE INCREASED 54 0.0024
461 ELECTROCARDIOGRAM ABNORMAL 19 0.0024
462 BONE MARROW FAILURE 49 0.0024
463 CARDIAC FAILURE ACUTE 16 0.0024
464 ADRENAL INSUFFICIENCY 29 0.0024
465 RETINAL HAEMORRHAGE 17 0.0024
466 ECONOMIC PROBLEM 36 0.0024
467 HYPOMAGNESAEMIA 33 0.0024
468 CARDIOMEGALY 29 0.0024
469 LIPASE INCREASED 18 0.0023
470 WHITE BLOOD CELL COUNT INCREASED 90 0.0023
471 HEPATOMEGALY 23 0.0023
472 BLOOD POTASSIUM INCREASED 38 0.0023
473 RASH PUSTULAR 17 0.0023
474 JOINT EFFUSION 16 0.0023
475 OSTEOMYELITIS 42 0.0023
476 BLISTER 129 0.0023
477 MUSCLE ATROPHY 29 0.0023
478 ORAL CANDIDIASIS 30 0.0023
479 HAEMATOMA 59 0.0023
480 NASAL DISCOMFORT 18 0.0023
481 LEFT VENTRICULAR DYSFUNCTION 15 0.0022
482 SKIN WARM 13 0.0022
483 JAUNDICE 60 0.0022
484 INFUSION SITE SWELLING 14 0.0022
485 PROTEINURIA 42 0.0022
486 HEPATIC CYTOLYSIS 28 0.0022
487 SUPRAVENTRICULAR TACHYCARDIA 21 0.0022
488 MELAENA 48 0.0022
489 INCONTINENCE 23 0.0022
490 INTERNATIONAL NORMALISED RATIO INCREASED 62 0.0022
491 ALANINE AMINOTRANSFERASE INCREASED 133 0.0022
492 FEMORAL NECK FRACTURE 11 0.0021
493 INJURY 150 0.0021
494 FAILURE TO THRIVE 11 0.0021
495 TROPONIN INCREASED 16 0.0021
496 PANCREATITIS ACUTE 47 0.0021
497 MOUTH ULCERATION 44 0.0021
498 PULMONARY OEDEMA 93 0.0021
499 ATRIOVENTRICULAR BLOCK 16 0.0021
500 ABSCESS 33 0.0021
501 EYELID OEDEMA 24 0.0021
502 VENTRICULAR TACHYCARDIA 34 0.0021
503 UNRESPONSIVE TO STIMULI 53 0.0021
504 DERMATITIS 43 0.0021
505 ASPARTATE AMINOTRANSFERASE INCREASED 109 0.0020
506 ACUTE HEPATIC FAILURE 28 0.0020
507 TORSADE DE POINTES 16 0.0020
508 ERYTHEMA OF EYELID 11 0.0020
509 RESPIRATORY RATE INCREASED 18 0.0020
510 DELIRIUM 70 0.0020
511 TREATMENT FAILURE 167 0.0020
512 THERAPY NON-RESPONDER 90 0.0020
513 SECRETION DISCHARGE 25 0.0020
514 TENDON DISORDER 13 0.0020
515 PAPULE 14 0.0020
516 LETHARGY 113 0.0020
517 DECUBITUS ULCER 16 0.0020
518 CARDIAC ARREST 162 0.0020
519 BRADYCARDIA 104 0.0020
520 RESPIRATORY ARREST 54 0.0020
521 POLYURIA 16 0.0020
522 MENTAL STATUS CHANGES 54 0.0019
523 CYTOKINE RELEASE SYNDROME 39 0.0019
524 OXYGEN SATURATION DECREASED 109 0.0019
525 VISUAL FIELD DEFECT 14 0.0019
526 POSTOPERATIVE WOUND INFECTION 13 0.0019
527 TENDERNESS 20 0.0019
528 NEUTROPHIL COUNT DECREASED 78 0.0019
529 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 105 0.0019
530 LIVE BIRTH 16 0.0019
531 LYMPHOPENIA 27 0.0019
532 HYPONATRAEMIA 107 0.0019
533 ECCHYMOSIS 13 0.0019
534 DISEASE PROGRESSION 223 0.0019
535 WHITE BLOOD CELL COUNT ABNORMAL 12 0.0019
536 SPLENOMEGALY 22 0.0019
537 FEELING OF BODY TEMPERATURE CHANGE 11 0.0019
538 FISTULA 21 0.0019
539 COLITIS 70 0.0018
540 OEDEMA 100 0.0018
541 THERMAL BURN 13 0.0018
542 ANAEMIA 349 0.0018
543 SEIZURE 208 0.0018
544 HEPATOTOXICITY 40 0.0018
545 HEPATIC FUNCTION ABNORMAL 67 0.0018
546 SMALL INTESTINAL OBSTRUCTION 22 0.0018
547 HYPOTHERMIA 18 0.0018
548 DRUG LEVEL DECREASED 18 0.0018
549 LACTIC ACIDOSIS 57 0.0018
550 ATRIAL FLUTTER 14 0.0018
551 DERMATITIS ALLERGIC 22 0.0017
552 BLOOD DISORDER 14 0.0017
553 RASH MACULAR 61 0.0017
554 INFLAMMATION 90 0.0017
555 BLOOD CREATINE PHOSPHOKINASE INCREASED 50 0.0017
556 PLATELET COUNT DECREASED 185 0.0017
557 CARDIAC MURMUR 15 0.0017
558 PRODUCT USE IN UNAPPROVED INDICATION 428 0.0017
559 NO THERAPEUTIC RESPONSE 21 0.0017
560 APPLICATION SITE VESICLES 11 0.0017
561 CONDITION AGGRAVATED 514 0.0017
562 SINUS TACHYCARDIA 24 0.0017
563 PNEUMONITIS 46 0.0017
564 RASH PRURITIC 90 0.0017
565 PLEURAL EFFUSION 101 0.0017
566 EXPOSURE DURING PREGNANCY 103 0.0017
567 PERICARDIAL EFFUSION 38 0.0016
568 BALANCE DISORDER 142 0.0016
569 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
570 DISORIENTATION 65 0.0016
571 ORAL HERPES 32 0.0016
572 DRUG EXPOSURE DURING PREGNANCY 55 0.0016
573 DUODENAL ULCER PERFORATION 12 0.0016
574 ATAXIA 19 0.0016
575 FLANK PAIN 15 0.0016
576 EYE INFECTION 18 0.0016
577 ARTERIOSCLEROSIS 15 0.0016
578 RASH GENERALISED 41 0.0016
579 LOWER RESPIRATORY TRACT INFECTION 72 0.0016
580 SCAB 18 0.0016
581 WOUND 44 0.0016
582 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
583 SKIN PLAQUE 13 0.0015
584 GASTROOESOPHAGEAL REFLUX DISEASE 124 0.0015
585 GRAND MAL CONVULSION 14 0.0015
586 NEUROPATHY PERIPHERAL 144 0.0015
587 HAEMATEMESIS 38 0.0015
588 RESPIRATORY TRACT INFECTION 39 0.0015
589 PULMONARY EMBOLISM 142 0.0015
590 MYOCARDIAL ISCHAEMIA 17 0.0015
591 DERMATITIS CONTACT 17 0.0015
592 TINNITUS 68 0.0015
593 SUBARACHNOID HAEMORRHAGE 15 0.0015
594 HAEMORRHAGE INTRACRANIAL 22 0.0015
595 RESPIRATORY DISORDER 44 0.0015
596 PALLOR 40 0.0015
597 NEOPLASM PROGRESSION 51 0.0015
598 HYPERCALCAEMIA 18 0.0015
599 CARDIAC FAILURE 117 0.0015
600 GENERALISED TONIC-CLONIC SEIZURE 24 0.0014
601 PARANOIA 25 0.0014
602 OSTEOPENIA 22 0.0014
603 INTERSTITIAL LUNG DISEASE 70 0.0014
604 VISUAL ACUITY REDUCED 48 0.0014
605 CYSTITIS 46 0.0014
606 URINARY RETENTION 48 0.0014
607 HAEMOGLOBIN DECREASED 147 0.0014
608 SKIN ULCER 37 0.0014
609 RASH PAPULAR 32 0.0014
610 CARDIOMYOPATHY 21 0.0014
611 GASTRIC ULCER 27 0.0014
612 PANCREATITIS 75 0.0014
613 LYMPHADENOPATHY 50 0.0014
614 HAEMATOCRIT DECREASED 28 0.0014
615 PULMONARY FIBROSIS 27 0.0014
616 GASTROINTESTINAL HAEMORRHAGE 117 0.0014
617 ANOREXIA 18 0.0014
618 HEPATIC ENCEPHALOPATHY 13 0.0014
619 GENERAL PHYSICAL HEALTH DETERIORATION 161 0.0014
620 APHASIA 42 0.0014
621 PLATELET COUNT INCREASED 18 0.0014
622 CHILLS 161 0.0014
623 HYPERGLYCAEMIA 50 0.0014
624 PERICARDITIS 23 0.0014
625 GROIN PAIN 12 0.0014
626 PNEUMONIA 441 0.0014
627 IMMUNOSUPPRESSION 12 0.0014
628 EYE DISCHARGE 14 0.0013
629 QUALITY OF LIFE DECREASED 18 0.0013
630 POLYNEUROPATHY 16 0.0013
631 NIGHT SWEATS 43 0.0013
632 ANAL INCONTINENCE 12 0.0013
633 AUTOIMMUNE DISORDER 13 0.0013
634 URINARY TRACT INFECTION 227 0.0013
635 HEART RATE IRREGULAR 30 0.0013
636 REBOUND EFFECT 15 0.0013
637 ATRIAL FIBRILLATION 129 0.0013
638 UNEVALUABLE EVENT 100 0.0013
639 DRUG-INDUCED LIVER INJURY 41 0.0013
640 RETINAL DETACHMENT 12 0.0013
641 VERTIGO 79 0.0013
642 BLOOD PRESSURE DECREASED 86 0.0013
643 ILEUS 16 0.0013
644 BLOOD MAGNESIUM DECREASED 11 0.0013
645 DEPRESSED LEVEL OF CONSCIOUSNESS 50 0.0013
646 VENTRICULAR FIBRILLATION 14 0.0013
647 CHOLECYSTITIS 15 0.0013
648 NERVOUS SYSTEM DISORDER 39 0.0012
649 UPPER GASTROINTESTINAL HAEMORRHAGE 21 0.0012
650 DYSTONIA 24 0.0012
651 DYSPEPSIA 121 0.0012
652 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
653 VITREOUS FLOATERS 12 0.0012
654 COORDINATION ABNORMAL 17 0.0012
655 HYPOGLYCAEMIA 59 0.0012
656 GASTRITIS 32 0.0012
657 LUNG DISORDER 59 0.0012
658 CEREBRAL HAEMORRHAGE 43 0.0012
659 PAIN IN JAW 34 0.0012
660 SCIATICA 19 0.0012
661 OESOPHAGITIS 13 0.0012
662 CHOLELITHIASIS 39 0.0012
663 MEDICATION ERROR 66 0.0012
664 HEPATIC STEATOSIS 22 0.0012
665 APPENDICITIS 11 0.0012
666 KIDNEY INFECTION 23 0.0012
667 DEEP VEIN THROMBOSIS 76 0.0012
668 EAR DISCOMFORT 12 0.0012
669 TOXICITY TO VARIOUS AGENTS 197 0.0012
670 SCAR 20 0.0012
671 PERIPHERAL COLDNESS 16 0.0012
672 WHEEZING 69 0.0012
673 VENTRICULAR EXTRASYSTOLES 12 0.0012
674 EYE INFLAMMATION 11 0.0012
675 EYE PAIN 65 0.0012
676 HAEMOPTYSIS 32 0.0011
677 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
678 MICTURITION URGENCY 13 0.0011
679 PRESCRIBED OVERDOSE 22 0.0011
680 DISEASE RECURRENCE 54 0.0011
681 DIZZINESS POSTURAL 11 0.0011
682 OEDEMA PERIPHERAL 138 0.0011
683 OSTEONECROSIS OF JAW 28 0.0011
684 INFECTION 163 0.0011
685 CARDIO-RESPIRATORY ARREST 47 0.0011
686 JOINT RANGE OF MOTION DECREASED 15 0.0011
687 PARALYSIS 16 0.0011
688 BLOOD SODIUM DECREASED 21 0.0011
689 CONFUSIONAL STATE 180 0.0011
690 DEHYDRATION 148 0.0011
691 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
692 CEREBRAL INFARCTION 27 0.0011
693 ACUTE MYELOID LEUKAEMIA 17 0.0011
694 BASAL CELL CARCINOMA 17 0.0011
695 SWOLLEN TONGUE 34 0.0011
696 ACUTE MYOCARDIAL INFARCTION 32 0.0011
697 CONVULSION 62 0.0011
698 BLOOD CALCIUM DECREASED 12 0.0011
699 ACCIDENTAL OVERDOSE 39 0.0011
700 PHOTOPHOBIA 20 0.0011
701 RESPIRATORY DEPRESSION 13 0.0011
702 SENSORY DISTURBANCE 17 0.0011
703 MUSCULAR WEAKNESS 120 0.0011
704 EMOTIONAL DISTRESS 127 0.0010
705 RASH 457 0.0010
706 PELVIC PAIN 19 0.0010
707 BONE DISORDER 19 0.0010
708 HALLUCINATION, VISUAL 22 0.0010
709 SEROTONIN SYNDROME 20 0.0010
710 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
711 TENDONITIS 16 0.0010
712 BLOOD POTASSIUM DECREASED 31 0.0010
713 RENAL DISORDER 48 0.0010
714 THERAPY PARTIAL RESPONDER 16 0.0010
715 CONTRAINDICATED PRODUCT ADMINISTERED 31 0.0010
716 SEXUAL DYSFUNCTION 12 0.0010
717 CYANOSIS 16 0.0010
718 ANGIOEDEMA 45 0.0010
719 INTRAOCULAR PRESSURE INCREASED 13 0.0010
720 OFF LABEL USE 889 0.0010
721 SWELLING FACE 66 0.0010
722 ARRHYTHMIA 48 0.0010
723 INFUSION SITE PAIN 13 0.0010
724 COMA 48 0.0010
725 SKIN EXFOLIATION 85 0.0010
726 ASPIRATION 11 0.0010
727 MASS 14 0.0010
728 ABDOMINAL PAIN 233 0.0010
729 DIPLOPIA 26 0.0010
730 HYPOACUSIS 43 0.0010
731 GASTROENTERITIS VIRAL 18 0.0010
732 SINUSITIS 102 0.0010
733 SKIN REACTION 14 0.0010
734 DYSPHAGIA 94 0.0010
735 DRUG INEFFECTIVE 1298 0.0010
736 ERYTHEMA 201 0.0010
737 EAR PAIN 19 0.0010
738 LIVER DISORDER 43 0.0010
739 ABDOMINAL DISTENSION 101 0.0010
740 LIP SWELLING 32 0.0010
741 HYPERSENSITIVITY 176 0.0009
742 COGNITIVE DISORDER 44 0.0009
743 OBESITY 15 0.0009
744 PULMONARY MASS 14 0.0009
745 IMMUNODEFICIENCY 14 0.0009
746 CHEST PAIN 173 0.0009
747 IRRITABLE BOWEL SYNDROME 20 0.0009
748 BLINDNESS 38 0.0009
749 IMPAIRED HEALING 30 0.0009
750 PHARYNGEAL OEDEMA 14 0.0009
751 ACTIVITIES OF DAILY LIVING IMPAIRED 18 0.0009
752 STOMATITIS 55 0.0009
753 DIABETES MELLITUS INADEQUATE CONTROL 16 0.0009
754 CYTOPENIA 11 0.0009
755 BURNING SENSATION 63 0.0009
756 FOOT FRACTURE 17 0.0009
757 BLOOD URINE PRESENT 17 0.0009
758 DIARRHOEA 573 0.0009
759 ULCER 14 0.0009
760 DRUG WITHDRAWAL SYNDROME NEONATAL 13 0.0009
761 ANXIETY 249 0.0009
762 EPISTAXIS 65 0.0009
763 AGITATION 63 0.0009
764 CATARACT 51 0.0009
765 HAEMORRHAGE 88 0.0008
766 ISCHAEMIC STROKE 15 0.0008
767 FEEDING DISORDER 17 0.0008
768 BEDRIDDEN 11 0.0008
769 LUNG INFECTION 13 0.0008
770 VOMITING 391 0.0008
771 HYPERTENSION 176 0.0008
772 WHITE BLOOD CELL COUNT DECREASED 90 0.0008
773 INFUSION RELATED REACTION 55 0.0008
774 MUSCLE TWITCHING 19 0.0008
775 INTESTINAL OBSTRUCTION 31 0.0008
776 ECZEMA 43 0.0008
777 DYSURIA 30 0.0008
778 RECTAL HAEMORRHAGE 35 0.0008
779 DECREASED APPETITE 189 0.0008
780 URTICARIA 135 0.0008
781 OVERDOSE 172 0.0008
782 DYSARTHRIA 30 0.0008
783 CARDIAC FAILURE CONGESTIVE 64 0.0008
784 FEELING COLD 22 0.0008
785 GALLBLADDER DISORDER 14 0.0008
786 HIP ARTHROPLASTY 12 0.0008
787 HYPOTHYROIDISM 25 0.0008
788 SKIN DISORDER 26 0.0008
789 MOBILITY DECREASED 56 0.0008
790 PRODUCT USE ISSUE 146 0.0008
791 HAEMORRHOIDS 15 0.0008
792 HEMIPARESIS 13 0.0008
793 SKIN DISCOLOURATION 35 0.0008
794 SYNCOPE 76 0.0008
795 CORONARY ARTERY DISEASE 23 0.0008
796 ALOPECIA 149 0.0008
797 SINUS DISORDER 15 0.0008
798 OSTEOARTHRITIS 32 0.0008
799 BLOOD PRESSURE ABNORMAL 15 0.0008
800 DRUG ADMINISTRATION ERROR 23 0.0007
801 MOVEMENT DISORDER 24 0.0007
802 DYSPNOEA 423 0.0007
803 ORTHOSTATIC HYPOTENSION 13 0.0007
804 LOCALISED INFECTION 18 0.0007
805 HYPOPHAGIA 19 0.0007
806 UPPER RESPIRATORY TRACT INFECTION 34 0.0007
807 HEPATIC ENZYME INCREASED 50 0.0007
808 COVID-19 128 0.0007
809 GLAUCOMA 14 0.0007
810 ILL-DEFINED DISORDER 44 0.0007
811 DRUG DISPENSING ERROR 11 0.0007
812 PRURITUS 276 0.0007
813 DYSPHONIA 42 0.0007
814 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
815 OCULAR HYPERAEMIA 34 0.0007
816 ABDOMINAL PAIN LOWER 18 0.0007
817 TREMOR 118 0.0007
818 CHROMATURIA 16 0.0007
819 IRRITABILITY 42 0.0007
820 NECK PAIN 39 0.0007
821 INTENTIONAL PRODUCT MISUSE 61 0.0007
822 SWELLING 65 0.0007
823 PRURITUS GENERALISED 15 0.0007
824 PRODUCTIVE COUGH 33 0.0007
825 HALLUCINATION 52 0.0007
826 APPLICATION SITE ERYTHEMA 18 0.0007
827 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
828 NEPHROLITHIASIS 31 0.0007
829 CONTUSION 65 0.0007
830 HERNIA 13 0.0007
831 EYE SWELLING 25 0.0007
832 DYSKINESIA 27 0.0007
833 VIRAL INFECTION 22 0.0007
834 HEART RATE INCREASED 65 0.0007
835 LIVER FUNCTION TEST INCREASED 14 0.0007
836 PRESCRIBED UNDERDOSE 13 0.0007
837 HYPOAESTHESIA 97 0.0006
838 URINARY INCONTINENCE 19 0.0006
839 DISCOMFORT 39 0.0006
840 DYSPNOEA EXERTIONAL 24 0.0006
841 ABNORMAL BEHAVIOUR 25 0.0006
842 GLOSSODYNIA 14 0.0006
843 BLOOD PRESSURE FLUCTUATION 15 0.0006
844 THROAT IRRITATION 28 0.0006
845 PALPITATIONS 73 0.0006
846 EPILEPSY 19 0.0006
847 COUGH 173 0.0006
848 NAUSEA 488 0.0006
849 HAEMATOCHEZIA 34 0.0006
850 VISION BLURRED 84 0.0006
851 BACK PAIN 142 0.0006
852 SLEEP DISORDER 43 0.0006
853 IMPAIRED WORK ABILITY 13 0.0006
854 ABASIA 15 0.0006
855 AGGRESSION 30 0.0006
856 PREGNANCY 12 0.0006
857 PAIN 366 0.0006
858 FULL BLOOD COUNT DECREASED 12 0.0006
859 HERPES ZOSTER 34 0.0006
860 MUSCULOSKELETAL PAIN 31 0.0006
861 EYE IRRITATION 34 0.0006
862 PROCEDURAL PAIN 16 0.0006
863 SOMNOLENCE 116 0.0006
864 WEIGHT DECREASED 160 0.0006
865 PARAESTHESIA 90 0.0006
866 BRONCHITIS 42 0.0006
867 GAIT DISTURBANCE 108 0.0006
868 EAR INFECTION 15 0.0006
869 LACRIMATION INCREASED 17 0.0006
870 INCORRECT DOSE ADMINISTERED 128 0.0006
871 RED BLOOD CELL COUNT DECREASED 16 0.0006
872 THROMBOSIS 45 0.0006
873 INTENTIONAL PRODUCT USE ISSUE 49 0.0006
874 MYALGIA 95 0.0006
875 MALAISE 244 0.0006
876 DEPRESSION 126 0.0006
877 LIMB DISCOMFORT 17 0.0005
878 GASTROINTESTINAL DISORDER 49 0.0005
879 DEMENTIA 15 0.0005
880 MENTAL IMPAIRMENT 13 0.0005
881 PRESYNCOPE 13 0.0005
882 INCORRECT ROUTE OF DRUG ADMINISTRATION 19 0.0005
883 FATIGUE 413 0.0005
884 ASTHENIA 199 0.0005
885 BONE PAIN 31 0.0005
886 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25 0.0005
887 CEREBROVASCULAR ACCIDENT 88 0.0005
888 OSTEOPOROSIS 21 0.0005
889 GAIT INABILITY 17 0.0005
890 ARTHRALGIA 211 0.0005
891 FAECES DISCOLOURED 11 0.0005
892 LOSS OF CONSCIOUSNESS 65 0.0005
893 DIZZINESS 253 0.0005
894 MUSCULOSKELETAL STIFFNESS 44 0.0005
895 JOINT STIFFNESS 13 0.0005
896 VISUAL IMPAIRMENT 61 0.0005
897 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
898 CONSTIPATION 107 0.0005
899 ANGINA PECTORIS 14 0.0005
900 MYOCARDIAL INFARCTION 85 0.0005
901 EYE DISORDER 16 0.0005
902 RHINORRHOEA 31 0.0005
903 POLLAKIURIA 20 0.0005
904 DYSSTASIA 14 0.0005
905 LIMB INJURY 13 0.0005
906 HOT FLUSH 36 0.0005
907 SPEECH DISORDER 25 0.0005
908 OROPHARYNGEAL PAIN 44 0.0005
909 TYPE 2 DIABETES MELLITUS 16 0.0005
910 FEELING HOT 29 0.0005
911 BLOOD PRESSURE INCREASED 72 0.0005
912 ARTHROPATHY 26 0.0005
913 HYPERHIDROSIS 59 0.0005
914 JOINT SWELLING 55 0.0005
915 EMOTIONAL DISORDER 14 0.0005
916 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
917 BLOOD CHOLESTEROL INCREASED 21 0.0005
918 DIABETES MELLITUS 34 0.0004
919 AMNESIA 29 0.0004
920 THERAPEUTIC RESPONSE DECREASED 27 0.0004
921 ARTHRITIS 35 0.0004
922 HEAD INJURY 14 0.0004
923 DRY EYE 22 0.0004
924 INFLUENZA LIKE ILLNESS 36 0.0004
925 PERIPHERAL SWELLING 67 0.0004
926 DIVERTICULITIS 12 0.0004
927 DRY MOUTH 35 0.0004
928 CHEST DISCOMFORT 44 0.0004
929 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
930 BONE DENSITY DECREASED 13 0.0004
931 MENTAL DISORDER 18 0.0004
932 PAIN IN EXTREMITY 121 0.0004
933 DISTURBANCE IN ATTENTION 22 0.0004
934 DEATH 351 0.0004
935 LABORATORY TEST ABNORMAL 12 0.0004
936 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
937 TREATMENT NONCOMPLIANCE 22 0.0004
938 NERVOUSNESS 21 0.0004
939 OSTEONECROSIS 13 0.0004
940 ASTHMA 44 0.0004
941 MYELOSUPPRESSION 14 0.0004
942 ABDOMINAL PAIN UPPER 80 0.0004
943 ILLNESS 40 0.0004
944 EYE PRURITUS 13 0.0004
945 RESTLESSNESS 14 0.0004
946 ROAD TRAFFIC ACCIDENT 16 0.0004
947 FALL 126 0.0004
948 ADVERSE DRUG REACTION 34 0.0004
949 INSOMNIA 98 0.0004
950 INFLUENZA 41 0.0004
951 HEADACHE 225 0.0004
952 PANIC ATTACK 13 0.0004
953 MEMORY IMPAIRMENT 49 0.0004
954 FLUID RETENTION 18 0.0004
955 DRUG INTOLERANCE 34 0.0004
956 ABDOMINAL DISCOMFORT 58 0.0003
957 PSORIATIC ARTHROPATHY 14 0.0003
958 HEART RATE DECREASED 12 0.0003
959 DEPRESSED MOOD 18 0.0003
960 HOSPITALISATION 52 0.0003
961 MUSCLE SPASMS 61 0.0003
962 FLUSHING 32 0.0003
963 MALIGNANT NEOPLASM PROGRESSION 32 0.0003
964 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
965 NASAL CONGESTION 18 0.0003
966 DRY SKIN 40 0.0003
967 VAGINAL HAEMORRHAGE 13 0.0003
968 CARDIAC DISORDER 28 0.0003
969 WEIGHT INCREASED 66 0.0003
970 ADVERSE EVENT 26 0.0003
971 NASOPHARYNGITIS 52 0.0003
972 RHEUMATOID ARTHRITIS 32 0.0003
973 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 48 0.0003
974 PSORIASIS 34 0.0003
975 SURGERY 15 0.0003
976 FEELING ABNORMAL 60 0.0003
977 MIGRAINE 23 0.0002
978 ACNE 18 0.0002
979 PRODUCT DOSE OMISSION ISSUE 69 0.0002
980 THERAPY CESSATION 12 0.0002
981 BLOOD GLUCOSE INCREASED 42 0.0002
982 DRUG EFFECT DECREASED 12 0.0002
983 DYSGEUSIA 15 0.0002
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
985 NO ADVERSE EVENT 35 0.0002
986 DEVICE MALFUNCTION 13 0.0002
987 SKIN BURNING SENSATION 13 0.0002
988 THERAPY INTERRUPTED 12 0.0002
989 PROSTATE CANCER 12 0.0001
990 PRODUCT STORAGE ERROR 12 0.0001
991 INJECTION SITE ERYTHEMA 17 0.0001
992 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
993 PRODUCT QUALITY ISSUE 14 0.0001
994 INJECTION SITE PAIN 30 0.0001
995 DRUG DOSE OMISSION 12 0.0001